4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-19-028931
Chief Financial Officer sold 30,000 shares at $13.73 ($412,029)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Robb Gary Charles · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-09 | Exercise or conversion : show line 1 in the form | +30,000 | $1.92 | $57,600 | 38,025 | D |
| 2019-12-09 | Sale : show line 2 in the form | −30,000 | $13.73 | $412,029 | 8,025 | D |
| Open-market sales · 30,000 sh · avg $13.73 · $412,029 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-09 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −30,000 | 45,000 | D |
Loading xslF345X03/doc4.xml…